The new approach relies on deep learning artificial intelligence technology. Like the ACC’s risk calculator, the AI method is also aimed at helping to “identify individuals who would benefit from statin medication but are currently untreated,” according to Jakob Weiss, M.D., lead author of the study (PDF) and a radiologist at Massachusetts General Hospital.
Commenti